Aim: This project aims to investigate the influence of Resin-Matrix Ceramics (RMCs) restorative materials (like GC Cerasmart 270 and Katana Avencia), on primary human gingival fibroblasts (ATCC PCS-201-018) (HGF) to evaluate biocompatibility of dental materials as an in vitro experimental model. Methods: Disk-shaped samples with 15 mm diameter and 1 mm thickness were tested as received from manufacturers on HGF. HGFs reside in the subepithelial connective tissue in which play a crucial role in maintenance of tissue integrity, wound healing and regeneration process. To evaluate biocompatibility of RMC materials, the influence on proliferation of HGF was tested at 1,3 and 7 days with Alamar Blue assay, at the same time point the inflammation was analysed with ELISA (specifically detecting the inflammatory factor IL-1β) and to assess the effect of RMCs on wound healing, scratch migration assay at 24 h, 28 h and 72 h was performed. Data were analysed using one-way repeated measure ANOVA and Tukey’s test. Results: Our data demonstrated that there was no significant difference in proliferation between HGFs in contact with disks and untreated control group (the cells were cultured on polystyrene plates in the absence of eluates) at each observed time point. Particularly, after 1 day, a growth inhibition of 2,2% was showed in GC Cerasmart 270 and 1,6% in Katana Avencia. At day 3, the percentage increased to 11,5% in GC Cerasmart 270 and 8,9% in Katana Avencia, while at day 7, the growth inhibition was 3,8% in GC Cerasmart 270 and 3,1% in Katana Avencia. Furthermore, there was no significant variance in the expression of IL-1β in treated cells compared to control group at each assessed time point, although a trend towards increase was noted at day 3 in both tested samples. Ultimately, the results from the scratch assay indicated that both materials did not exert any influence on the wound healing capacity. Conclusions: In conclusion this study showed that there are no statistically differences in biocompatibility between GC and AV and that both dental materials are clinically acceptable. The results of our research give a considerable contribut to the implementation of restorative procedures, and we express the hope that this experimental study will be further advanced.

Biocompatibility of Resin-Matrix Ceramics (RMCs) on Human Gingival Fibroblasts / Mastrosimone, A., Eccellente, A., Spagnuolo, G., Esposito, L., Ruggiero, G., Sorrentino, R., Del Giudice, C.. - (2024). (CED/NOF-IADR Oral Health Research Congress 2024 ).

Biocompatibility of Resin-Matrix Ceramics (RMCs) on Human Gingival Fibroblasts

Mastrosimone A.;Spagnuolo G.;Ruggiero G.;Sorrentino R.;
2024

Abstract

Aim: This project aims to investigate the influence of Resin-Matrix Ceramics (RMCs) restorative materials (like GC Cerasmart 270 and Katana Avencia), on primary human gingival fibroblasts (ATCC PCS-201-018) (HGF) to evaluate biocompatibility of dental materials as an in vitro experimental model. Methods: Disk-shaped samples with 15 mm diameter and 1 mm thickness were tested as received from manufacturers on HGF. HGFs reside in the subepithelial connective tissue in which play a crucial role in maintenance of tissue integrity, wound healing and regeneration process. To evaluate biocompatibility of RMC materials, the influence on proliferation of HGF was tested at 1,3 and 7 days with Alamar Blue assay, at the same time point the inflammation was analysed with ELISA (specifically detecting the inflammatory factor IL-1β) and to assess the effect of RMCs on wound healing, scratch migration assay at 24 h, 28 h and 72 h was performed. Data were analysed using one-way repeated measure ANOVA and Tukey’s test. Results: Our data demonstrated that there was no significant difference in proliferation between HGFs in contact with disks and untreated control group (the cells were cultured on polystyrene plates in the absence of eluates) at each observed time point. Particularly, after 1 day, a growth inhibition of 2,2% was showed in GC Cerasmart 270 and 1,6% in Katana Avencia. At day 3, the percentage increased to 11,5% in GC Cerasmart 270 and 8,9% in Katana Avencia, while at day 7, the growth inhibition was 3,8% in GC Cerasmart 270 and 3,1% in Katana Avencia. Furthermore, there was no significant variance in the expression of IL-1β in treated cells compared to control group at each assessed time point, although a trend towards increase was noted at day 3 in both tested samples. Ultimately, the results from the scratch assay indicated that both materials did not exert any influence on the wound healing capacity. Conclusions: In conclusion this study showed that there are no statistically differences in biocompatibility between GC and AV and that both dental materials are clinically acceptable. The results of our research give a considerable contribut to the implementation of restorative procedures, and we express the hope that this experimental study will be further advanced.
2024
Biocompatibility of Resin-Matrix Ceramics (RMCs) on Human Gingival Fibroblasts / Mastrosimone, A., Eccellente, A., Spagnuolo, G., Esposito, L., Ruggiero, G., Sorrentino, R., Del Giudice, C.. - (2024). (CED/NOF-IADR Oral Health Research Congress 2024 ).
File in questo prodotto:
File Dimensione Formato  
Poster IADR 2024 Mastrosimone finale.pdf

accesso aperto

Tipologia: Versione Editoriale (PDF)
Licenza: Dominio pubblico
Dimensione 643.6 kB
Formato Adobe PDF
643.6 kB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11588/1063418
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? ND
social impact